TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
JSPR

Jasper Therapeutics Inc

Healthcare · Biotechnology

0.6178$ -2.6% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Jasper Therapeutics Inc (JSPR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 36 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet JSPR
Line item 2019 2020 2021 2022 2023 2024 2025
27 23 94 48 95 80 36
27 21 88 42 89 76 35
27 20 85 38 87 72 29
27 20 85 38 87 72 29
0.6 0.7 1.2 0.3
0.1 -0.5
2.0 4.8 3.6
6.1 58 24 12 16 18 32
2.0 4.0 8.0 7.1 12 15 13
0.5 0.9 1.0 1.1 1.2
0.6 1.4 3.9 1.8 4.1 4.0 6.2
13
21 -35 70 36 78 62 4.2
-5.1 -37 -67 -105 -170 -241 -317
0.2 0.2 1.1 3.6 10 15 19

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?